Is OptiNose Inc (OPTN) Stock at the Top of the Drug Manufacturers

OptiNose Inc (OPTN) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. OPTN received an overall rating of 49, which means that it scores higher than 49 percent of all stocks. OptiNose Inc also achieved a score of 72 in the Drug Manufacturers - Specialty & Generic industry, putting it above 72 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 128 out of the 148 industries.

OPTN has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on OPTN!

See Full OPTN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With OptiNose Inc Stock Today?

OptiNose Inc (OPTN) stock is higher by 1.45% while the S&P 500 has fallen -1.45% as of 3:55 PM on Tuesday, Dec 6. OPTN has gained $0.02 from the previous closing price of $1.73 on volume of 198,874 shares. Over the past year the S&P 500 is lower by -14.17% while OPTN has gained 6.02%. OPTN lost -$0.95 per share the over the last 12 months. Click Here to get the full Stock Report for OptiNose Inc stock.